253: Use of Tocilizumab in the Treatment of COVID-19
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000726900.86356.9c
Abstract: INTRODUCTION: Severely ill patients with COVID-19 pneumonia have been found to have an extensive cytokine mediated inflammatory response This has been demonstrated by elevated pro-inflammatory markers, including interleukin 6 (IL-6) Tocilizumab is an IL-6 antagonist… read more here.
Keywords: use tocilizumab; administration; treatment; received tocilizumab ... See more keywords